Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Oshen Holdings General Information
Oshen Holdings is a European-based family office investing in innovative biotech and medtech life sciences focused on improving quality of life as we age ("Better Ageing"). It leads or participates in funding rounds for early-stage companies developing novel therapeutics and medical devices. Recent activities include co-development agreements with Topadur Pharma AG for a topical treatment for alopecia and leading the Series A round for 4D Medicine, which develops bioresorbable medical device materials.
Contact Information
Primary Industry
Investors
Corporate Office
,
Luxembourg
Luxembourg
Drug Pipeline
No pipeline data available
Key Partnerships
Topadur Pharma AG – co-development/licensing agreement on TOP-M119 for Greater China region, 4D Medicine – lead investor role/funding partner on bioresorbable implant technology development
Oshen Holdings Funding
No funding data available
To view Oshen Holdings's complete valuation and funding history, request access »